|
1
|
A prognostic DNA methylation signature for stage I non-small-cell lung cancer.
|
J Clin Oncol
|
2013
|
1.47
|
|
2
|
Intrinsic cancer subtypes--next steps into personalized medicine.
|
Cell Oncol (Dordr)
|
2015
|
0.90
|
|
3
|
Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.84
|
|
4
|
Phase I study of concurrent chemoradiation with pemetrexed and cisplatin followed by consolidation pemetrexed for patients with unresectable stage III non-small cell lung cancer.
|
Lung Cancer
|
2011
|
0.82
|
|
5
|
Epigenetic regulation of vitamin D metabolism in human lung adenocarcinoma.
|
J Thorac Oncol
|
2014
|
0.76
|